Factors influencing symptom expression in children with bronchial hyperresponsiveness at 10 years of age

Ramesh J Kurukulaaratchy1, Sharon Matthews, Linda Waterhouse

  • 1David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Newport, Isle of Wight, United Kingdom.

Insights

In children with bronchial hyperresponsiveness (BHR), current wheezing is linked to atopic sensitization and maternal asthma. Early life factors like parental smoking and atopy also predict symptomatic BHR.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Epidemiology

Background:

  • Wheezing is a common respiratory symptom in children.
  • Bronchial hyperresponsiveness (BHR) is a key feature of asthma.
  • Identifying factors associated with symptomatic BHR is crucial for early intervention.

Purpose of the Study:

  • To identify factors associated with wheezing symptoms in children with bronchial hyperresponsiveness (BHR) at 10 years of age.
  • To explore the influence of early-life genetic and environmental exposures on symptomatic BHR.

Main Methods:

  • A population-based birth cohort study followed 1456 children from birth to 10 years.
  • Prospective data collection on genetic and environmental risk factors.
  • Methacholine bronchial challenge at 10 years identified BHR (PC(20) FEV(1) < 4.0 mg/mL); logistic regression analyzed factors associated with current wheezing.

Main Results:

  • BHR was present in 169 children; 55.6% had current wheeze.
  • Current wheezers with BHR showed higher total IgE and greater BHR.
  • Symptomatic BHR was associated with atopic sensitization and maternal asthma at age 10.
  • Early-life (by age 4) parental smoking, maternal asthma, and atopic sensitization predicted symptomatic BHR.

Conclusions:

  • Symptomatic BHR in children is linked to increased BHR severity and elevated total IgE.
  • Heredity, atopy, and environmental exposures play a role in the expression of symptoms in children with BHR.
Abstract

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...